Larson Financial Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$199 Sell
3
-6
-67% -$508 ﹤0.01% 3604
2026
Q1
$895 Sell
9
-7
-44% -$913 ﹤0.01% 3190
2025
Q4
$1.95K Buy
16
+8
+100% +$1K ﹤0.01% 2786
2025
Q3
$898 Sell
8
-15
-65% -$1.76K ﹤0.01% 2953
2025
Q2
$3.08K Buy
+23
New +$2.52K ﹤0.01% 2268

Other funds holding TMDX

Larson Financial Group's TMDX Position: Q2 2026 in Review

Larson Financial Group reduced its Transmedics (TMDX) stake by 67% in Q2 2026, selling an estimated $508 and leaving 3 shares worth $199. The position accounts for ﹤0.01% of the portfolio, ranked #3604.

Larson Financial Group first reported a position in TMDX in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.08K in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Larson Financial Group held 3 shares of Transmedics worth $199 as of Q2 2026.
  • Larson Financial Group sold 6 Transmedics shares in Q2 2026, an estimated $508.
  • Transmedics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3604 holding.
  • Larson Financial Group first reported a position in Transmedics in Q2 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Transmedics position peaked at $3.08K in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.